Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivione Biosciences
Houston, Texas, United States
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
The RAPID-B platform has demonstrated proof-of-concept and commercial use in rapid microbiology testing for food safety, infectious diseases, and industrial microbiology, providing bacterial detection results in minutes to hours instead of days. Clinical test launches included tuberculosis and prion diagnostics, with further expansion into sepsis and antibiotic susceptibility testing underway[2][4].
- Therapeutic areas
- Infectious DiseasesNeurology
- Modalities
- DeviceDiagnostic reagent
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
National Center for Toxicological Research (NCTR, FDA)University of ArkansasKirkegaard & Perry (now SeraCare)[2]
Beyond the preview
Go deeper on Vivione Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vivione Biosciences.